Advancing Diverse Representation in Clinical Trials and Research

HealthVerity offerings support the call for action by the Committee on Improving Representation of Women and Underrepresented Minorities in Clinical Trials and Research.

Exploring how de-identified longitudinal real-world data fuels evidence generation at speed and scale

Highlights from the 2022 INFORMS Business Analytics Conference

Exploring how de-identified longitudinal real-world data fuels evidence generation at speed and scal...

Highlights from the 2022 INFORMS Business Analytics Conference

Observations from the 2022 ILTCI Conference

Exploring the impacts and benefits of a real-world data strategy for long-term care insurance carriers

The HealthVerity IPGE Platform: A transformational approach for the modern healthcare enterprise

In a recent HealthVerity LIVE webinar, we took an in-depth look at how the HealthVerity IPGE (Identity, Privacy, Governa...

Enriching clinical trials with real-world data

COVID-19 urgently highlighted the need for real-time data, and with it, the need to tap into a wider variety of data sou...

Accurate, de-identified patient data: The key to a longitudinal patient journey

A data-rich longitudinal patient journey is key to research and development, commercialization and marketing in the worl...

The modern way to data: An executive conversation with AWS

This post was originally published on the AWS for Industries blog by Jared Saul, Global Head of Healthcare and Life Scie...

How RWE can support drug development during COVID-19 and beyond: Q&A with Dr. Diana Brainard of ...

The COVID-19 pandemic introduced novel challenges for global biopharma organizations, as many adapted their clinical tri...

Subscribe to the HealthVerity blog

Contact us